Navigation Links
Brooks Instrument's New Mass Flow Controller Series Is Immune to Pressure and Temperature Fluctuations
Date:3/11/2009

Fluctuations
The B-Series is a pressure- and temperature-insensitive device. The mass flow controller actively measures line pressure and adjusts the control valve to virtually eliminate actual flow and flow signal changes as a result of pressure fluctuations. In addition, the output of every B-Series mass flow controller is characterized over the full operating temperature range of the device allowing superior measurement and control accuracy regardless of process or ambient temperature conditions.

Unique Advanced Diagnostics
The B-Series incorporates sophisticated internal self-diagnostic routines that continuously check the health of the device. In the event of a diagnostic fault, an alarm code flashes on the user interface. An easy to use service port provides additional diagnostic capability, minimizing the need to remove the mass flow controller from process service.

Visit BrooksInstrument.com for more information about the Brooks B-Series mass flow controller.
   
About Brooks Instrument
Brooks Instrument is a world-leading flow measurement and control instrument provider, with headquarters in Hatfield, PA USA, and manufacturing locations, regional sales, and service offices in the Americas, Europe, and Asia. Brooks' products include glass and metal tube variable area meters (rotameters), thermal mass flow meters and controllers,

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. New Flexible Vacuum Controller from Varian, Inc. is Expandable and Easy to Use
2. Controllers Stem Cell Agency Audit Ignores California Agencys Built-in Flaws
3. Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
4. Sopherion Therapeutics Secures $55 Million in Series C Funding
5. NanoBio Corporation Raises $12 Million in Series B Financing
6. Divergence Raises $11.8 Million in Series C Financing
7. Immune Targeting Systems Completes Second Tranche of Series-A Funding Bringing Total Funds Raised to More Than GBP5m
8. MODA Offers Paperless QC Micro Webinar Series on Automating Environmental Monitoring, Utility and Product Testing
9. TaiGen Biotechnology Secures 37 Million USD in Series C Round Financing
10. Intradigm Closes Final Tranche of $21.4 Million Series B Financing
11. Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Brooks Instrument's New Mass Flow Controller Series Is Immune to Pressure and Temperature Fluctuations 
(Date:11/24/2014)... November 24, 2014 Continental Clinical ... populations into clinical trials at its mid-Atlantic late-phase ... “Continental was created with the idea of closing ... fundamental role in medical advances," said Continental's CEO, ... experiment to the immortal cell line of Henrietta ...
(Date:11/24/2014)... , Nov. 24, 2014  Spherix Incorporated (Nasdaq: ... committed to the fostering and monetization of intellectual ... VTech Telecommunications Ltd.,  Case No. 3:13-cv-03494-M and  Spherix ... 3:13-cv-03496-M, both in the United States District Court ... . On November 21, ...
(Date:11/22/2014)... November 21, 2014 Two new educational webinars ... comes next for ALS research and how the pharmaceutical industry ... the Ice Bucket Challenge: Where Does the ALS Money Go? ... 2 December 2014, Time: 1:30pm ET, Register to ... speaker Dr. Merit Cudkowicz, Julianne Dorn Professor of Neurology at ...
(Date:11/22/2014)... 2014 CannLabs, Inc. (OTCQB: ... and scientific testing methodologies relating to cannabis, today announced ... line of credit from an existing stockholder of the ... secured this commitment from one of our existing stockholders,” ... “This capital will help accelerate our planned expansions into ...
Breaking Biology Technology:At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3Markman Hearing Held as Scheduled in VTech and Uniden Cases 2DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2CannLabs Secures $750,000 Line Of Credit 2
... (NASDAQ: NBIX ) announced today that it ... initial cohort of Tardive Dyskinesia patients using its proprietary ... this data, the Company is initiating the Investigational New ... Drug Administration (FDA). "We are very pleased ...
... announces that a new market research report is ... Sequencing - technologies, markets and companies ... report briefly reviews basics of human genome variations, ... large and small sequencers are described as well ...
... 2011 Caliper Life Sciences, Inc. (NASDAQ: ... for drug discovery and life-sciences research, today announced that ... formed a research collaboration with Denver-based Catholic Health Initiatives ... The health care system,s Center for Translational Research ...
Cached Biology Technology:Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor 2Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor 3Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor 4Reportlinker Adds DNA Sequencing - Technologies, Markets and Companies 2Caliper Announces New Oncology Research Collaboration 2Caliper Announces New Oncology Research Collaboration 3
(Date:11/18/2014)...   News Highlights: ... The Partners Data Lake, an agile data and ... will allow researcher and clinicians to explore and ... lives of patients , The Partners Data ... the Partners system, breaking down physical barriers for ...
(Date:11/11/2014)... Nov. 11, 2014  Forensicon, Inc., a ... pleased to announce the promotion of Yaniv Schiff ... Digital Forensics. In Schiff,s new role as Director, he ... of digital forensics examiners and provide leadership within the ... - http://photos.prnewswire.com/prnh/20141110/157719 Schiff joined ...
(Date:11/6/2014)... team of Florida State University biologists could lead to ... and survive environmental swings such as droughts or floods. ... the journal The Plant Cell , sheds light ... is organized in a cell and how plants regulate ... and others are turned off. , "If you understand ...
Breaking Biology News(10 mins):Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Maize analysis yields whole new world of genetic science 2
... FL, January 30, 2014 Scientists from the Florida ... awarded approximately $1.8 million from the National Cancer Institute ... signaling pathways that underlie lung cancer and to use ... Kissil, a TSRI associate professor, will be principal investigator ...
... say they have opened the window on the natural process of ... could be used to advance therapies for bone fractures and disease. ... the Feb. 13 issue of the journal Cell Reports , ... to allow adult zebra fish to perfectly replace bones lost upon ...
... in German . ... neurons in the brain. Nerve growth factors produced by the body, ... tests with GDNF have not yielded in any clear improvements. Scientists ... colleagues have now succeeded in demonstrating that GDNF and its receptor ...
Cached Biology News:Zebra fish fins help Oregon researchers gain insight into bone regeneration 2Parkinson gene: Nerve growth factor halts mitochondrial degeneration 2Parkinson gene: Nerve growth factor halts mitochondrial degeneration 3